14. October 2020 - 8:00 till 12:00
Online, Online
Share it on:

Remote MAT Training | Wednesday, 14. October 2020

We look forward to you guys attending out virtual event!

About this Event


Sign up for and attend a 4 hour virtual webinar via computer taught by Dr. Karen Hartwell from MUSC. Once completed, participants will receive the second half of the course – a 4 hour online self-study portion. At the end of the course, participants are required to pass an exam with a 75% or higher before applying for their waiver. APRNs and PAs are required to take a few more steps to obtain their DATA Waiver. Click to learn more. AAAP is the DATA 2000 sponsor for this training.

AT THE CONCLUSION OF THIS ACTIVITY PARTICIPANTS SHOULD BE ABLE TO: 1. Screen and identify patients with OUD and define evidence-based treatments. 2. Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients. 3. Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient. 4. Explain the process of buprenorphine induction as well as stabilization and maintenance. 5. Discuss all FDA approved antagonist and agonist medications to treat OUD. 6. Discuss basic office protocols including dical record documentation and confidentially. 7. Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD. 8. Recognize the importance of obtaining a waiver to begin treating patients with OUD.

Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by the American Academy of Addiction Psychiatry, South Carolina Primary Health Care Association and South Carolina Office of Rural Health. American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Ph*rm*cy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. Interprofessional Continuing Education (IPCE) Designation Statement: This activity was planned by and for the healthcare team, and learners will receive 8 (eight) Interprofessional Continuing Education credits for learning and change.

Physician Designation Statement: American Academy of Addiction Psychiatry designates this Other activity (one portion of this course is an independent online activity and another portion of this course is a live ****-to-**** educational exchange with a clinical expert trained to present this material) for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing Designation Statement: American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider # 4008192. This program is approved for up to 8 Nursing Contact Hours. PA Designation Statement: American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA and grant no. GA1RH33542 from FORHP. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.